Cargando…
Bone-Targeted Agents and Metastasis Prevention
SIMPLE SUMMARY: Bone metastases are common in cancer patients and the role of bone-targeted agents in prevention of metastasis have been evaluated in multiple clinical trials over the past 20 years. Results show that in breast cancer the use of adjuvant bisphosphonates (and possibly denosumab) reduc...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367604/ https://www.ncbi.nlm.nih.gov/pubmed/35892899 http://dx.doi.org/10.3390/cancers14153640 |